Osteoarthritis (OA) is a degenerative articular disorder manifested by cartilage destruction, subchondral sclerosis, osteophytes, and synovitis, resulting in chronic joint pain and physical disability in the elderly. The purpose of this study was to investigate mitochondrial DNA copy number (mtDNA CN ) and inflammatory cytokines in primary knee OA patients and healthy volunteers. A total of 204 knee OA patients and 169 age-matched healthy volunteers were recruited. Their relative blood leukocyte mtDNA CN was assessed by quantitative real-time polymerase chain reaction (qRT-PCR), and ten inflammatory cytokines in their plasma were detected by multiplex immunoassay. Blood leukocyte mtDNA CN in the OA group was significantly lower than that in the control group. Leukocyte mtDNA CN in the control group was negatively correlated with their age (r=−0.380, P<0.0001), whereas mtDNA CN in the OA group was positively correlated with their age (r=0.198, P<0.001). Plasma interleukin-4 (IL-4) and IL-6 were significantly higher in the knee OA group than in the control group. The plasma IL-6 level was positively correlated with blood leukocyte mtDNA CN in the OA group (r=0.547, P=0.0014). IL-5 showed as a major factor (coefficient 0.69) in the second dimension of principle components analysis (PCA)-transformed data and was significantly higher in the OA group (P<0.001) as well as negatively correlated with mtDNA CN (r=−0.577, P<0.001). These findings suggest that elevation of plasma IL-4 and IL-6 and a relative reduction in mtDNA CN might be effective biomarkers for knee OA. IL-5 is a plausible factor responsible for decreasing blood leukocyte mtDNA CN in knee OA patients.
Introduction
Osteoarthritis (OA) is a typical degenerative articular disorder resulting in chronic joint pain and physical disability in the elderly. It has been characterized by fibrillation, sclerosis, osteophyte formation, and progressive destruction of the articular cartilage (Manoy et al., 2018) . Multiple risk factors have been identified in the various stages of OA development such as gender, obesity, joint injury, senescence, and genetic factors. However, the etiology and pathogenesis of OA remain poorly understood. A number of biochemical and genetic factors have been documented as playing critical roles in the progression of OA.
Mitochondria produce energy by synthesizing adenosine triphosphate (ATP) to drive normal cellular physiological functions. Mitochondrial DNA (mtDNA) does not contain introns or histones, and the oxidative damage level may be slightly lower in mtDNA than in nuclear DNA (Lim et al., 2005) . The fundamental mechanisms underlying mitochondrial dysfunction in OA involve increased chondrocyte apoptosis, decreased chondrocyte biosynthesis, cytokine-induced chondrocyte inflammation, and cartilage matrix calcification. Mitochondrial dysfunction in OA chondrocytes could stem from somatic mutations in the mtDNA or from the direct effects of proinflammatory cytokines and reactive oxygen species (ROS) (Blanco et al., 2011) . The mtDNA copy number (mtDNA CN ) decreases with age in adults over fifty, and thus mtDNA biogenesis is important to maintain an appropriate mtDNA CN content to slow down cellular aging (Dechsupa et al., 2017) . Recent studies have demonstrated that mtDNA CN was associated with osteoarthritis and might play a contributory role in the pathological process of OA (Fang et al., 2014; Zhan and Honsawek, 2019) .
A few inflammatory cytokines or chemokines are highly expressed in the circulation system of the elderly and maintain a low-grade systemic inflammatory condition (Hsu et al., 2009; Schaap et al., 2009; López-Otín et al., 2013) . Mitochondria and mtDNA content can influence low-grade systemic inflammation by various mechanisms. Systemic inflammation can be upgraded through weakening of the mitochondrial biogenesis of macrophages (Chawla et al., 2011) . Recently, leukocyte mtDNA CN was found to be negatively correlated with highsensitivity C-reactive protein (hs-CRP), white blood cell count, and interleukin-6 (IL-6), and associated with oxidative stress in the elderly (Tanpaisankit et al., 2017; Wu et al., 2017) . Inflammatory cytokines with high expression not only affect systemic and local conditions of OA, but also are crucial in synthesizing cartilage and regulating the extracellular matrix (Kapoor et al., 2011; Mabey et al., 2016) .
Both mtDNA content and knee OA are related to low-grade inflammatory reactions and the aging progress, and therefore it is necessary to investigate mtDNA CN and its relationships with inflammatory cytokines. The purpose of this study was to evaluate blood leukocyte mtDNA CN and inflammatory cytokines in patients with knee OA compared to those in a control group, and to determine the relationships between mtDNA CN and inflammatory cytokines in knee OA patients.
Materials and methods

Study population
The study was approved by the Institutional Review Board (IRB number 565/59) on Human Research of the Faculty of Medicine, Chulalongkorn University, Thailand, and was conducted in compliance with the guidelines of the Declaration of Helsinki. All subjects gave written informed consent prior to their participation in this study.
A total of 204 patients with unilateral primary knee OA (age range 50-80 years) were recruited in the OA group. OA patients were identified by diagnostic criteria of the American College of Rheumatology. Patients who had other chronic inflammatory diseases, immunological abnormalities, prior knee trauma, or knee surgery were excluded from the study. A total of 169 healthy volunteers (age range 50-80 years) with normal knee radiographs, without symptoms, signs, or a previous history of OA participated as the control group.
The knee radiographs of controls and OA subjects were categorized using the Kellgren-Lawrence (KL) classification system (Kellgren and Lawrence, 1957) . The healthy volunteers had a KL grade of 0. Every patient included in the OA group had a KL grade equal to or greater than 2: 50 patients were Grade 2, 64 patients Grade 3, and 90 patients Grade 4. All patients were hospitalized at least one day before a knee arthroscopy or total knee replacement operation. The researchers were blinded as to which group each participant had been assigned. Serial numbers were randomly selected for labeling the biological samples from participants.
Sample preparation
Whole blood samples collected into sodium heparin-coated tubes (Greiner Bio-one, Chonburi, Thailand) were centrifuged at 4000g for 10 min to obtain blood leukocytes. Genomic DNA was then extracted from the leukocytes using an Illustra Blood Genomic Prep Mini Spin kit (GE Healthcare, Buckinghamshire, UK). The quality and concentration of the extracted DNA were identified using a NanoDrop 1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). The genomic DNA was aliquoted and stored at −80 °C until measurement. Among all participants, plasma samples of 12 healthy volunteers and 31 knee OA subjects were available for multiplex immunoassay. All plasma specimens were stored at −80 °C until further analysis.
Measurement of blood leukocyte mtDNA CN
The relative mtDNA CN was determined using quantitative real-time polymerase chain reaction (qRT-PCR) as described previously (Xing et al., 2008) . DNA samples were amplified in 10-μL reactions using a Step One Plus Real Time PCR system (Applied Biosystems, Foster City, CA, USA). The primer sequences for the mitochondrial nicotinamide adenine dinucleotide (NADH) dehydrogenase 1 (ND1) gene were: ND1 F, 5'-CCCTAAAACCCGCCACAT CT-3' and ND1 R, 5'-GAGCGATGGTGAGAGCTA AGGT-3'. The primer sequences for the nuclear human β-haemoglobin (HGB) gene were: HGB F, 5'-G TGCACCTGACTCCTGAGGAGA-3' and HGB R, 5'-CCTTGATACCAACCTGCCCAG-3'. Both reactions contained 5 μL qPCR Green Master Mixes (2×) (Biotech Rabbit, Germany), 2 μL DNA template (1.56 ng/mL), and 0.2 μL forward and reverse primers (10 μmol/L). The thermal cycling profile for both the ND1 and HGB genes started with 95 °C incubation for 30 s for 1 cycle, followed by 35 cycles of 94 °C for 30 s, 58 °C for 30 s, and 72 °C for 50 s. All amplification specificity was regulated by melting curve analysis. Threshold cycle (C T ) values were used to calculate the qRT-PCR results. An unchanged DNA sample was used as reference which was placed in the same well position of the tray. Each sample mtDNA CN was estimated by the comparative method using the fold induction 2 −ΔΔC T equation (Livak and Schmittgen, 2001) . The ΔC T was determined by calculating the difference between the average C T value of the ND1 gene and that of the HGB gene. The difference between the sample ΔC T and reference ΔC T gave the ΔΔC T value.
Measurement of plasma cytokines
The levels of ten commonly tested cytokines in plasma were examined by magnetic bead-based multiplex measurement on 96-well plates (Bio-Plex Precision Pro, Bio-Rad, Hercules, USA). These 10-type beads were coupled by ten cytokine antibodies: IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α. Briefly, 50 μL of the coupled beads were added to the experimental wells. After washing, 50 μL of standards and plasma of OA patients or healthy volunteers were transferred into each well with beads and incubated for 1 h. Next, the detecting antibodies were added and incubated for 30 min. Streptavidinphycoerythrin (streptavidin-PE) of appropriate concentration was added to each well and incubated for 10 min. Finally, assay buffer was added to resuspend the beads. A Bio-Plex 200 array reader (Bio-Plex 200 Multiplex System, Bio-Rad, Hercules, USA) was used to measure the levels of cytokines in suspension.
Statistical analysis
All qualitative and quantitative variables were analyzed with software R Version 4.3.2 and GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA). Quantitative data are presented as mean±standard error of mean (SEM). Qualitative data are presented as frequencies. The normality of the quantitative data was identified by a Shapiro-Wilk test, and an F-test was used to check for homogeneity of the variance. Student's t-test and Welch's test were used for unpaired normal data based on the variance equality. Variables not normally distributed were analyzed by the Wilcoxon test. Qualitative data were analyzed by a Pearson χ 2 test to examine the frequency. Linear correlations of two variables were analyzed by Pearson's correlation for normal data and Spearman's correlation for non-normal data. Logistic regression analysis models were performed to determine the association between mtDNA CN and cytokines by taking age, gender, and body mass index (BMI) as the covariates.
To investigate the interactions of multiple cytokines with mtDNA CN and disease, all detectable cytokines were integrated into different dimensions/ components by applying principle components analysis (PCA) to reveal the potential variables. The number of dimensions was collected from evidence of scree plots and the Kaiser-Harris criterion for eigenvalues greater than 1. A non-rotation method was used in PCA to display data features. Interpretation of each dimension was supported by a high absolute value of eigenvalue loading coefficients. The calculation of individual dimension scores for each participant was based on detectable inflammatory cytokines. Differences between the control and OA groups in each dimension were analyzed with these scores. Subsequently, the correlations between standardized mtDNA CN (mean=0, standard deviation (SD)=1) and individual scores of each dimension in different groups were analyzed using a simple linear model. P<0.05 was considered to indicate a significant difference.
Results
Clinical characteristics of the participants
Demographic data of the patients included in this study are displayed in Table 1 . There were no significant age differences between groups (P=0.132). The number of females was significantly higher in the OA group than in the control group (P<0.001). The mean BMI was significantly lower in the control group than in the OA group (P<0.001).
Correlation of mtDNA CN and age in patients with knee OA
The mean blood leukocyte mtDNA CN of the OA group was significantly lower than that of the control group (0.50±0.03 vs. 1.07±0.04, P<0.0001; Fig. 1 ). There were no significant differences in mtDNA CN among various KL grades of the OA group (P= 0.3277). However, the blood leukocyte mtDNA CN of OA patients with KL Grade 2, 3, or 4 was significantly lower than that of controls (P<0.0001; Fig. 1 ). In the control group, the mtDNA CN was negatively correlated with the age of healthy participants (r= −0.380; P<0.0001). However, the mtDNA CN increased with age in the OA group (r=0.198, P=0.0025). Thus, the relationships between age and mtDNA CN showed opposing linear correlations in the control and OA groups.
Inflammatory cytokine levels in plasma
Plasma samples from 12 healthy volunteers and 31 OA patients were used to assess the levels of inflammatory cytokines. The levels of two cytokines, IL-4 and IL-6, were significantly greater in the OA patients than in the controls (P=0.003 and P<0.001, respectively; Table 2 ). The levels of IL-1β, IL-2, IL-5, IL-10, IL-12p70, IL-13, and TNF-α were higher in the OA group, but the differences were not significant. Plasma IFN-γ was undetectable in the control group, but was detected in four participants in the OA group.
Correlation of cytokines and mtDNA CN
Since ten paired inflammatory cytokine levels and mtDNA CN were acquired from 43 participants, a matrix correlation analysis was applied to interpret Fig. 2a . Blue circles demonstrate that most inflammatory cytokines in the control group were positively correlated with other cytokines (P<0.05). In the OA group, only IL-6 was positively correlated with mtDNA CN (r=0.547, P=0.0014; Fig. 2b ). Blank squares represent undiscovered relationships between each cytokine and mtDNA CN . In the OA group, there were no associations between IL-6 and other inflammatory cytokines, except for IL-1β (r=0.361, P=0.0458). The other cytokines showed positive associations with each other. As age, gender, and BMI can influence the findings, we performed logistic regression analyses to determine the correlation between plasma cytokines and blood leukocyte mtDNA CN of OA patients by taking age, gender, and BMI as the covariates. We observed no significant correlation between blood leukocyte mtDNA CN and plasma cytokines in the knee OA patients.
Principle components analysis
Eigenvalues of the three dimensions were greater than 1; the first dimension had an eigenvalue 0 (dark red) . The presence of a circle indicates a significant correlation (P<0.05); conversely, blank squares indicate no significance (P>0.05). All coefficients were computed by Spearman's rho rank correlation for possible pairs of variables in the matrix of 5.47, the second 1.11, and the third 1.06 (Fig. 3) . These three dimensions accounted for 60.8%, 12.3%, and 11.7% of the variance for the nine cytokine variables, respectively, and all three cumulative dimensions accounted for 84.5% of the variance in the height variables (Table 3) . All nine detectable cytokines were positively correlated with the first dimension, which suggested that the nine variables worked together to produce the effects seen in OA. The first dimension was highly correlated with IL-13, TNF-α, IL-2, IL-10, and IL-1β whose correlation coefficients were more than 0.90. Therefore, this dimension was a predominant measurement for these five cytokines. Although correlation coefficients for IL-4 and IL-12p70 were more than 0.5, they were not considered to be the main variables in the first dimension. As the coefficient value was just 0.06 for IL-6, this dimension could not be regarded as a measure of IL-6. There were no statistical differences between the OA and the control groups in the first dimension. Also, there were no significant correlations with standardized mtDNA CN in either group (Table 3) .
In the second dimension, the coefficient for IL-5 increased to 0.69, and four cytokines (IL-5, IL-4, IL-12p70, and IL-6) were then positively correlated with this dimension (Table 3, Fig. 4a ). The mean individual score for the OA group was higher than that of the control group in the second dimension. The standardized mtDNA CN was negatively correlated with the individual scores in the second dimension for the OA group (r=−0.577, P<0.001), but there was no significant correlation for the control group.
In the third dimension, IL-6 became the only predominant factor, with a coefficient value of 0.94. In contrast, IL-5 was negatively correlated to this dimension, with a coefficient value of 0.40 (Table 3 , Fig. 4b) . Other values were less than or equal to 0.11. The mean score of the control group was significantly different to that of the OA group (P<0.0001). There was no significant correlation between the cytokines studied and the standardized mtDNA CN for each group (Table 3) .
Discussion
Few studies have described the mtDNA content from peripheral blood leukocytes of patients with primary knee OA. Our study demonstrated that blood leukocyte mtDNA CN was lower in OA patients than in
Fig. 3 Scree plot of inflammatory cytokines
The eigenvalues of dimensions 1, 2, and 3 were more than 1 healthy participants. We found that IL-4 and IL-6 concentrations were significantly higher in OA patients. Moreover, IL-6 was significantly and positively correlated with mtDNA CN in OA patients. Results from the PCA indicated that underlying dimensions of multiple cytokines and mtDNA CN affected knee OA. Blood leukocyte mtDNA CN was higher in knee OA patients and inversely correlated to dimension 2 in which IL-5 was the major factor. IL-5 was higher in patients with knee OA. In dimension 3, IL-6 was the major factor and IL-6 levels were higher in the OA group. These results suggest that these cytokines may contribute to the biological characteristics of primary OA and may cause chronic lowgrade inflammation.
Abnormal mtDNA CN can disrupt the gene expression, differentiation, and migration of normal cells (Liu et al., 2015) . Mitochondria dysfunction of peripheral leucocytes may be associated with OA development by increasing ROS and apoptosis (Meyer et al., 2013; Yang et al., 2013) . Previous studies found that leukocyte mtDNA was lower in patients with various diseases including metabolic syndrome, cancer, and neurodegenerative diseases (Chomyn and Attardi, 2003) . Fang et al. (2014) reported that mtDNA CN was higher in knee OA subjects compared to controls, but the mtDNA CN did not differ among various subgroups of OA subjects. The explanations for these conflicting results remain unclear, but might be due to differences in clinical settings, disease advancement, populations, ethnic groups, or the assays applied. Age is an influential factor for mtDNA CN . In the general population, mtDNA content and age show a non-linear relationship; the mtDNA content of people over 50 years old has been shown to decrease with their age (Dechsupa et al., 2017) . Our findings from the healthy volunteers also showed that age was negatively correlated with relative mtDNA CN .
Inflammation has been recognized as a contributor to the symptoms and progression of OA, especially in cartilage and the synovium (Smith et al., 1997; Blanco et al., 2011) . Cytokines and mediators of local inflammatory events involve circulating blood. Numerous studies reported that several inflammation-related cytokines were higher in OA blood (Attur et al., 2012; Berenbaum, 2013; Mabey et al., 2016) . Low-grade, systemic, and chronic inflammation might be a pivotal sign or factor for initiating or developing the disorder (Blanco et al., 2018) .
IL-6 is a pro-inflammatory cytokine which decreases type II collagen and increases matrix metalloproteinases (Porée et al., 2008; Kapoor et al., 2011) . Higher concentrations of IL-6 have been found in Fig. 4 Biplots showing cytokine coefficients with positive or negative effects in dimensions 1, 2, and 3 Participants' component scores were plotted against each other and in group-dependent clusters: the principle components analysis (PCA) biplot for dimensions 1 versus 2 (a) and dimensions 1 versus 3 (b). Dim: dimension; Ctrl: control; OA: osteoarthritis plasma and sera of OA patients (Kaneko et al., 2000; Mabey et al., 2016) . In a 15-year follow-up study, researchers discovered that IL-6 was consistently upregulated in patients with radiographic knee OA (Livshits et al., 2009) . In contrast, lower IL-6 levels have been found to decrease the probability of development into OA by 87.01% (Goekoop et al., 2010) . IL-6 is also recognized as a myokine, which increases by up to 100-fold compared to the baseline level when skeletal muscle contracts during aerobic exercise. IL-6 may be acutely secreted and have an antiinflammatory effect (Pedersen and Febbraio, 2008) . Prolonged higher levels of IL-6 in the blood can maintain low-grade, chronic, and systemic inflammation in OA patients instead of the benefits of acute IL-6 production by myocytes.
As an anti-inflammatory cytokine, IL-4 regulates macrophage action to decrease inflammation, regulate lipid accretion, inhibit the expression of a few pro-inflammatory cytokines, and increase glucose tolerance (Chang et al., 2012) . IL-4 levels were higher in plasma of the OA group in this and our previous studies (Mabey et al., 2016) . However, the serum IL-4 concentration was lower in the OA model of a rat study (Guo et al., 2015) . These contrasting results were found in real cases of knee OA and in an animal model of OA using an identical IL-4 epitope recognized by serum IL-4 receptor and antibodies of the immunoassay. More importantly, blood IL-4 levels vary with different stages of knee OA: the IL-4 level of early knee OA (EOA) is higher than that of advanced knee OA (AOA) (Barker et al., 2014) . We speculate that low-grade systemic inflammation of OA induces IL-4 release into circulating blood in EOA. However, increased IL-4 promotes an increase in soluble IL-4 receptor (IL-4R) to maintain a balanced IL-4/IL-4R system (Silvestri et al., 2006) . The advantage of IL-4 effects can be blocked by increasing the levels of soluble IL-4 receptor which downregulates IL-4 activity and quantity in AOA.
Type 2 helper T cells and mast cells express IL-5 to induce eosinophil activation, adhesion, chemotaxis, and the release of other inflammatory cytokines and chemokines (Ashraf et al., 2015) . Vangsness et al. (2011) reported that the amount of IL-5 in synovial fluid (SF) in the knee was higher in AOA patients, according to the International Cartilage Repair Society (ICRS) classification. Six cytokine genes, IL-4, , colony stimulating factor 2 (CSF2), and IL-3, are located close together in the 5q31-33 region of the human genome, forming a cytokine cluster (Thomas et al., 1997) . Thus, variation in IL-5 could be influenced by IL-4 gene expression. This was confirmed by a report that IL-5 production could be down-regulated in CD4 + T cells of IL-4 gene knock-out mice (Kopf et al., 1993) .
Our study applied PCA to identify patterns within complicated biological data. The mtDNA CN has been negatively correlated with CRP-related factors such as IL-6, fibrinogen, leukocyte count, and hs-CRP in the elderly (Wu et al., 2017) . Although our research did not find any correlation between leukocyte mtDNA CN and plasma IL-6 level in healthy volunteers, IL-6 was positively correlated with mtDNA CN in elderly patients with knee OA. The impact of IL-6 on mtDNA CN probably was influenced by IL-5. According to dimension 3 of the PCA, the scoring coefficient of IL-5 was −0.40, whereas that of IL-6 was 0.94. When IL-5 became the largest positive coefficient (0.69) in dimension 2, it was negatively correlated with blood leukocyte mtDNA CN in the OA group. Yousefi et al. (2008) revealed that, after stimulation of eotaxin, lipopolysaccharide (LPS), or complement factor 5a (C5a), IL-5-pre-treated eosinophils were capable of releasing mtDNA into extracellular areas resulting in a decline in intracellular mtDNA. Moreover, this process was dependent on ROS.
The current study had several limitations that should be noted. First, the sampling of a relatively small number of subjects in one single site cannot represent the general population. Larger scale, multicenter studies should be conducted to verify our conclusions. Second, the mtDNA CN of all participants from the controls and OA participants has been investigated, but the limited availability of plasma inflammatory cytokine data from controls and knee OA patients posed significant challenges in the study. Another caveat is the lack of data regarding in vitro cell culture models of human chondrocytes. Further studies of mtDNA CN and cytokines in human primary chondrocytes obtained from healthy control and OA subjects will be useful for validating the findings of this study. Lastly, the cross-sectional design prevented determination of cause-and-effect relationships, and the potential for confounding variables needs to be taken into consideration.
In conclusion, blood leukocyte mtDNA CN in the knee OA subjects was significantly lower than that in the controls. Plasma IL-4 and IL-6 were significantly greater in the knee OA cases than in the controls. The plasma IL-6 level was positively correlated with blood leukocyte mtDNA CN in knee OA. PCA showed that IL-5 was a major factor and was significantly higher in the OA patients and negatively correlated with blood leukocyte mtDNA CN . High levels of IL-4 and IL-6 are potential biomarkers for OA disease diagnosis and pathophysiology. IL-5 could be responsible for the decline in blood leukocyte mtDNA CN in primary knee OA.
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